SCHEMBL167464

SCHEMBL167464

C=C(NCC(=O)O)OC(C)N

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.42
ALDH1A1 P00352 1/20 0.42
LMNA P02545 1/20 0.42
PTGS2 P35354 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
EGLN1 Q9GZT9 2/20 0.39
ECE1 P42892 1/20 0.38
MME P08473 2/20 0.37
ACE P12821 2/20 0.37
CPA1 P15085 1/20 0.37
ACE2 Q9BYF1 1/20 0.37
GABRP O00591 2/20 0.33
GABRD O14764 2/20 0.33
GABRA1 P14867 2/20 0.33
GABRB1 P18505 2/20 0.33
GABRG2 P18507 2/20 0.33
GABRB3 P28472 2/20 0.33
GABRA5 P31644 2/20 0.33
GABRA3 P34903 2/20 0.33
GABRA2 P47869 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1249763 0.98 MAPT (0.41) MAPTALDH1A1LMNAPTGS2TDP1
SCHEMBL28024880 0.81 ALDH1A1 (0.40) MAPTALDH1A1LMNAPTGS2TDP1
SCHEMBL2163387 0.77 ALDH1A1 (0.39) MAPTALDH1A1LMNAPTGS2TDP1
SCHEMBL350857 0.74
SCHEMBL17137742 0.74 MAPT (0.47) MAPTALDH1A1LMNAPTGS2TDP1
SCHEMBL29213759 0.73
Val-Gly SCHEMBL2782029 0.69 ALDH1A1 (0.57) MAPTALDH1A1LMNAPTGS2TDP1
SCHEMBL8735296 0.69 EGLN1 (0.59) MAPTALDH1A1LMNAPTGS2TDP1
Val-Gly SCHEMBL2782025 0.69 ALDH1A1 (0.57) MAPTALDH1A1LMNAPTGS2TDP1
SCHEMBL4013697 0.69 EGLN1 (0.39) MAPTALDH1A1LMNAPTGS2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1055 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260033508-A1 TREATING PERISHABLES WITH AN ETHYLENE-INHIBITING COMPOUND IN CONNECTION WITH A VACUUM ENVIRONMENT RIPELOCKER LLC (US) 2026-02-05 US claimed
EP-4175478-B1 METHODS OF INCREASING ALMOND YIELD VALENT USA LLC (US) 2025-12-17 EP claimed
US-20250325551-A1 GASOTRANSMITTER METABOLITES AND ALZHEIMER'S DISEASE UNIV LOUISIANA STATE (US) 2025-10-23 US claimed
US-20250287944-A1 AMINOETHOXYVINYLGLYCINE AND 1-AMINO-1-CYCLOPROPANECARBOXYLIC ACID AND USES THEREOF VALENT BIOSCIENCES LLC (US) 2025-09-18 US claimed
US-20250261603-A1 METHODS OF MAKING FEMINIZED CANNABIS SATIVA SEED AND COMPOSITIONS THEREOF FLORAGEN, LLC 2025-08-21 US claimed
CN-120130470-A Processing method for quick dyeing and fresh-keeping cooperative treatment of cut flowers of starfish and special preparation 云南花益美生物科技有限责任公司 2025-06-13 CN claimed
CN-119949225-A Method for promoting flowers of cut flowers of starfish after picking 云南花益美生物科技有限责任公司 2025-05-09 CN claimed
US-12280058-B2 Gasotransmitter metabolites and Alzheimer's disease BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) 2025-04-22 US claimed
CN-117717077-A Reagent and method for controlling plant dew and bituminous coal disease 海南品优种苗科技有限公司 2024-03-19 CN claimed
WO-2024052927-A1 NOVEL POLYMERIC FILM AND PAPER BASED PACKAGING SYSTEM TO DECELERATE SENESCENCE OF CLIMACTERIC AND NON-CLIMACTERIC HORTICULTURE PRODUCE ORIENT PRESS LIMITED (IN) 2024-03-14 WO claimed
EP-0767607-B1 USE OF COMPOUNDS WHICH INHIBIT EHTYLENE BIOSYNTHESIS IN HIGHER PLANTS FOR SOIL IMPROVEMENT BASF AG (DE) 1998-11-25 EP claimed
US-5837653-A AQUEOUS POLYVINYL ALCOHOL DISPERSION OF SUBSTITUTED OXIME-ETHER; FREE OF THICKENER AND SALT BASF CORPORATION (US) 1998-11-17 US claimed
US-5801119-A TREATING WITH 1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID SYNTHASE INHIBITOR ABBOTT LABORATORIES (US) 1998-09-01 US claimed
WO-1998028979-A1 A PROCESS FOR INHIBITING STEM ELONGATION IN BULBOUS PLANTS ABBOTT LABORATORIES (US) 1998-07-09 WO claimed
WO-1997022252-A9 AMINOETHOXYVINYLGLYCINE IN COMBINATION WITH MEPIQUAT CHLORIDE 1997-09-12 WO claimed
WO-1997022252-A1 AMINOETHOXYVINYLGLYCINE IN COMBINATION WITH MEPIQUAT CHLORIDE BASF CORPORATION (US) 1997-06-26 WO claimed
US-5637484-A CULTURING TISSUES OR CELLS OF PLANT BELONGING TO GENUS TAXUS IN PRESENCE OF JASMONIC ACID, RECOVERING TAXANE MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1997-06-10 US claimed
US-5510315-A MIXTURE OF AND/OR REACTION PRODUCT OF SILVER COMPOUND, PRIMARY AMINE, NUCLEIC ACID-RELATED SUBSTANCE MEIJI MILK PRODUCTS COMPANY LIMITED (JP) 1996-04-23 US claimed
EP-0683232-A1 PROCESS FOR PRODUCING TAXANE DITERPENE AND METHOD OF HARVESTING CULTRED CELL CAPABLE OF PRODUCING TAXANE DITERPENE IN HIGH YIELD MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1995-11-22 EP claimed
EP-0566749-A1 FRESHNESS RETENTIVE FOR CUT FLOWER MEIJI MILK PRODUCTS COMPANY LIMITED (JP) 1993-10-27 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260033508-A1 TREATING PERISHABLES WITH AN ETHYLENE-INHIBITING COMPOUND IN CONNECTION WITH A VACUUM ENVIRONMENT MVD, TOE1, PRUNE1 MAPT 4407/4885ALDH1A1 3076/4885LMNA 3662/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.